362
Participants
Start Date
September 5, 2025
Primary Completion Date
June 30, 2027
Study Completion Date
August 31, 2027
Mirogabalin
For the mirogabalin group, therapy will begin at 5mg twice daily. If the pain will remain inadequately controlled after one week without significant adverse effects, the dose will be escalated in 5 mg per day increments at weekly intervals, with a maximum allowable dose of 15mg twice daily.
Pregabalin
For the pregabalin group, treatment will be initiated at a dosage of 150 mg daily, administered into 2 or 3 divided doses. After 3 to 7 days, the dose will be titrated to 300 mg per day, with subsequent incremental increases of 150 mg daily permitted at 3-day to 7-day intervals based on therapeutic response and tolerability, up to a maximum dose of 600 mg daily.
RECRUITING
Beijing Tiantan Hospital, Beijing, Beijing 100070, Beijing
Second Affiliated Hospital of Nanchang University
OTHER
Chongqing Three Gorges Central Hospital
OTHER
the First People Hospital of Yunnan Province
UNKNOWN
China-Japan Friendship Hospital
OTHER
The First Affiliated Hospital of Nanchang University
OTHER
Peking University Third Hospital
OTHER
Beijing Tiantan Hospital
OTHER